Abstract

The lysophosphatidylinositol (LPI) has crucial roles in multiple physiological processes, including insulin exocytosis from pancreatic islets. However, the role of LPI in secretion of glucagon-like peptide-1 (GLP-1), a hormone that enhances glucose-induced insulin secretion, is unclear. Here, we used the murine enteroendocrine L cell line GLUTag and primary murine small intestinal cells to elucidate the mechanism of LPI-induced GLP-1 secretion. Exogenous LPI addition increased intracellular Ca2+ concentrations ([Ca2+] i ) in GLUTag cells and induced GLP-1 secretion from both GLUTag and acutely prepared primary intestinal cells. The [Ca2+] i increase was suppressed by an antagonist for G protein-coupled receptor 55 (GPR55) and by silencing of GPR55 expression, indicating involvement of Gq and G12/13 signaling pathways in the LPI-induced increased [Ca2+] i levels and GLP-1 secretion. However, GPR55 agonists did not mimic many of the effects of LPI. We also found that phospholipase C inhibitor and Rho-associated kinase inhibitor suppressed the [Ca2+] i increase and that LPI increased the number of focal adhesions, indicating actin reorganization. Of note, blockage or silencing of transient receptor potential cation channel subfamily V member 2 (TRPV2) channels suppressed both the LPI-induced [Ca2+] i increase and GLP-1 secretion. Furthermore, LPI accelerated TRPV2 translocation to the plasma membrane, which was significantly suppressed by a GPR55 antagonist. These findings suggest that TRPV2 activation via actin reorganization induced by Gq and G12/13 signaling is involved in LPI-stimulated GLP-1 secretion in enteroendocrine L cells. Because GPR55 agonists largely failed to mimic the effects of LPI, its actions on L cells are at least partially independent of GPR55 activation.

Highlights

  • The lysophosphatidylinositol (LPI) has crucial roles in multiple physiological processes, including insulin exocytosis from pancreatic islets

  • These findings suggest that TRPV2 activation via actin reorganization induced by Gq and G12/13 signaling is involved in LPI-stimulated glucagon-like peptide-1 (GLP-1) secretion in enteroendocrine L cells

  • Application of LPI to the cells induced the translocation of TRPV2 to the plasma membrane revealed by total internal reflection fluorescence microscopy. These results suggest that LPI induces GLP-1 secretion from enteroendocrine L cells through the activation of the G protein-coupled receptor 55 (GPR55), Rho-associated kinase (ROCK), and TRPV2 pathways

Read more

Summary

Results

To examine the effect of LPI on GLP-1 secretion from enteroendocrine L cells, we first monitored intracellular Ca2ϩ dynamics using the Ca2ϩ-sensing dye Fluo-4 AM in GLUTag cells. Silencing of endogenous GPR55 expression using a specific siRNA significantly suppressed the LPI-induced [Ca2ϩ]i increase (Fig. 2, D and E, and supplemental Fig. S1B) These results suggest that GPR55 functions as a receptor through which LPI induces [Ca2ϩ]i increase in enteroendocrine L cells. This treatment significantly suppressed LPI-induced [Ca2ϩ]i increase and GLP-1 secretion (Fig. 4, E–G, and supplemental Fig. S1D). The increase in the fluorescence intensity of TRPV2-EGFP was significantly suppressed by co-application of O-1918 with LPI (Fig. 5C) These results suggest that LPI-induced TRPV2 translocation to the plasma membrane is involved in the [Ca2ϩ]i increase and GLP-1 secretion. Application of GPR55 agonist, O-1602, had little effect on [Ca2ϩ]i, fluorescence intensity of TRPV2-EGFP, or GLP-1 secretion (Fig. 6). We confirmed expression of TRPV2 mRNA in GLUTag cells by RT-PCR

The focus of our research was to explore whether LPI induces
Experimental procedures
Plasmid construction
Cell culture and plasmid transfection
Total internal reflection fluorescence microscopy
Acute preparation of primary cultured mouse small intestinal cells
Imaging data analysis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.